Demographic characteristics.
therapyMissing, HIV or schistosomiasis separately or combined.
SCHISTOSOMIASIS
SD: standard deviation; MSCE: Malawi school certificate of education; ART: antiretroviral therapyMissing values, denominator = 6,297: age 3(0.05%); marital status 6 (0.10%); literacy 5 (0.08%); education level 4 (0.06%); tested for HIV before 4 (0.06%); tested for HIV in the last 12 months 4 (0.06%); currently on ART 7 (0.11%); circumcision status 6 (0.10%); ever taken praziquantel 9 (0.14%); taken praziquantel in the last 12 months 9 (0.14%); know friend or relative who died of HIV 270 (4.29%); self-rated general health 3 (0.05%); willingness to attend beach clinic offering HIV services 8 (0.13%); willingness to attend beach clinic offering schistosomiasis services 13 (0.21%); willingness to attend beach clinic offering both HIV and schistosomiasis services 13 (0.21%).Most partcipants (4,959, 78.8%) reported that they had previously tested for HIV; 373 (5.9%) reported taking antiretroviral therapy (ART). Overall, 71.1% (4,472) reported having taken praziquantel for schistosomiasis, with only 38.8% (n = 1,733) receiving a treatment course in the preceding 12 months. Overall, most (99%, 6224/6297) of the participants reported they would be willing to attend a beach clinic offering services for HIV or schistosomiasis separately or combined.There was considerable variation in the reported lifetime testing for HIV across the 45 clusters (